Home | Free 14-Day Trial | Tutorial | Help
Medical Disability Advisor  >  Anxiety Disorder Generalized  >  Treatment  see more: ACOEM - Stress-related Conditions

Anxiety Disorder, Generalized


Related Terms


  • GAD
  • Generalized Anxiety Disorder

Differential Diagnoses


Specialists


  • Clinical Psychologist
  • Internal Medicine Physician
  • Psychiatrist

Comorbid Conditions


  • Alcohol/substance abuse
  • Cardiovascular conditions
  • Irritable bowel syndrome
  • Major depressive disorder
  • Psychiatric illnesses
  • Sleep disorders

Sign-in as a subscriber or take a free trial to see the renowned Reed Group physiological recovery durations in place of this advertising.

Factors Influencing Duration


The severity of the symptoms, response to treatment, coexistence of substance abuse (especially alcohol dependence), other psychological disorders, underlying medical condition(s), ego strength of the individual, and the individual's social support system can affect the length of disability.

Duration Trends from Reference Data


DURATION TRENDS
 ICD-9-CM: 300.02  
CasesMeanMinMaxNo Lost TimeOver 6 Months
27865002161.5%1.3%
 
  
 
Percentile:5th25thMedian75th95th
Days:6183669147
 
  
 

Differences may exist between the duration tables and the reference graphs. Duration tables provide expected recovery periods based on the type of work performed by the individual. The reference graphs reflect the actual experience of many individuals across the spectrum of physical conditions, in a variety of industries, and with varying levels of case management. Selected graphs combine multiple codes based on similar means and medians.

Medical Codes


ICD-9-CM:
300.00 - Anxiety State, Unspecified; Neurosis, Reaction, State (Neurotic), Atypical Anxiety Disorder
300.02 - Generalized Anxiety Disorder

Treatment


Once the diagnosis of GAD has been made, treatment may include psychotherapy, relaxation training, biofeedback, and pharmacotherapy. Cognitive behavioral therapy, a type of psychotherapy often practiced in a group format, has developed the strongest empirical base. Antidepressant medications such as selective serotonin reuptake inhibitors (SSRIs) are the drugs of choice in treatment of GAD. Benzodiazepines are useful for acute situations or where the duration of therapy is expected to be less than 6 weeks. Chronic benzodiazepine use may lead to tolerance, dependency, and withdrawal symptoms.

Source: Medical Disability Advisor






Feedback
Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment. If you are seeking medical advice, please contact your physician. Thank you!
Send this comment to:
Sales Customer Support Content Development
 
This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is published with the understanding that the author, editors, and publisher are not engaged in rendering medical, legal, accounting or other professional service. If medical, legal, or other expert assistance is required, the service of a competent professional should be sought. We are unable to respond to requests for advice. Any Sales inquiries should include an email address or other means of communication.